A study on the effect of hinguvadi churna in managing enlarged prostate symptoms in men.

A single arm clinical study to evaluate the efficacy of Hinguvadi churna in the management of Astheela with special reference to Benign Prostatic Hyperplasia(BPH). - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112639

Enrollment

Registered

2026-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Patients having difficulty in urination - Pain and discomfort in bladder region -Obstructed or delayed urination -willing to give informed consent

Exclusion criteria

Exclusion criteria: - history of prostate or bladder cancer -Prior prostate surgery -Presence of urinary tract infection -Neurogenic bladder or other neurological conditions affecting urination - Use of medication affecting urinary function( e.g., anticholinergics, alpha blockers not being studied) -Severe renal impairment

Design outcomes

Primary

Measure	Time frame
To Reduce the size and volume of prostate on giving medicationTimepoint: 30 days The trial drug is given for 30 days and then follow up is done every week.	—

Secondary

Measure	Time frame
To assess the parameter for difficulty in urination and defecation with pain and discomfort in bladder region.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Dixant Sharma

Jeevan jyoti ayurvedic medical college and hospital, Aligarh

Yati_tiwari@yahoo.com8445733813

Outcome results